BRIEF COMMUNICATION
We stratifi ed ERC patients by sex, 5-year age interval at ERC, calendar year of ERC in 5-or 6-year intervals (1977 -1982, 1983 -1988, 1989 -1993, 1994 -1998, or 1999 -2003) , and indication for ERC (ie, fi rst three characters of the primary diagnosis code given at the time of ERC). Within each stratum, each sphincterotomy patient was matched with a patient without sphincterotomy. All unmatched patients were excluded from the analyses, as were all patients in strata with fewer than 10 matched sphincterotomy patients.
We used the primary and secondary diagnoses recorded in the National Patient Registry to examine whether ERC patients had been diagnosed with primary sclerosing cholangitis, liver cirrhosis, chronic infection with hepatitis B or C virus, diabetes, or infl ammatory bowel disease, all of which are risk factors for cholangiocarcinoma (7, 8) , before ERC.
For all ERC patients, follow-up began on the date of discharge after hospitalization for ERC and ended on the date of the fi rst cholangiocarcinoma diagnosis, death from any cause, or emigration or on December 31, 2003, whichever occurred fi rst. Patients who had ERC without sphincterotomy were censored at their fi rst sphincterotomy during follow-up. Cholangiocarcinomas were categorized as histologically verifi ed intrahepatic, histologically verifi ed extrahepatic, or unspecifi ed.
We computed the cumulative risks of cholangiocarcinoma and death from any cause for ERC patients and for 10 control subjects from the general population of Denmark per sphincterotomy patient ( 9 ) ; the control subjects were matched to the Endoscopic retrograde cholangiography (ERC) is a procedure used to diagnose disorders of the bile ducts, pancreas, and gallbladder. Upon diagnosis, treatment may involve sphincterotomy of the ampulla of Vater, which is done during the same procedure ( 1 -3 ). However, sphincterotomy allows refl ux of intestinal content into the biliary tree, which can lead to chronic infl ammation and malignant transformation of the biliary epithelium ( 4 -6 ). We compared cholangiocarcinoma incidence rates among ERC patients who had and had not undergone sphincterotomy.
We used the National Patient Registry to identify all Danish citizens who underwent an ERC in Denmark between January 1, 1977, and December 31, 2003 (see Appendix Table 1 for all procedure and diagnostic codes). This registry contains data from every hospitalization in Danish hospitals after 1977 and from outpatient visits after 1995. The data include the dates of hospital admission and discharge, surgical procedures, primary diagnosis, and secondary diagnoses. For patients who had undergone ERC multiple times, we considered only the earliest ERC. We excluded patients who had been diagnosed with cholangiocarcinoma before or at the time of ERC and patients who underwent ERC because cancer was suspected; all remaining patients were included in this study. Cholangiocarcinoma diagnoses recorded in the National Patient Registry were supplemented with those recorded in the Danish Cancer Registry. This registry, established in 1943, is notifi ed of every cancer diagnosed in Denmark, including its diagnosis date, a diagnosis code, and topography and histology codes. Data from the two registries were linked through the Central Offi ce of Civil Registration, which records the sex and dates of birth, death, and emigration of all Danish citizens. ERC patients by sex and brith year and were identifi ed through the Central Offi ce of Civil Registration. We used a proportional subdistribution hazards model ( 10 ) to estimate the cholangiocarcinoma incidence rate ratio for ERC patients with sphincterotomy compared with ERC patients without sphincterotomy. The model included sphincterotomy, age at ERC, sex, calendar year of ERC, indication for ERC, and whether ERC patients had primary sclerosing cholangitis, liver cirrhosis, chronic hepatitis B or C infection, diabetes, or infl ammatory bowel disease. The assumption of proportional subdistribution hazards was examined with Schoenfeld residuals, as described by Fine and Gray ( 10 ) , and tested by including the interaction between sphincterotomy and log followup time in the model. The examination with Schoenfeld residuals indicated that the hazards were not proportional over the entire follow-up period, as seen in the right-hand panel of Figure 1 : the curve is not a horizontal line. Hence, we divided the follow-up period into four periods (year 1, year 2, years 3 -5, and >5 years after ERC). The test based on the interaction term indicated that hazards were proportional within each of these four time periods. We examined whether any variable in the model had a statistically signifi cant ( P < .05) interaction with sphincterotomy. Finally, we repeated the matching of ERC patients with and without sphincterotomy and the subsequent analyses 1000 times and described the resulting distribution of cholangiocarcinoma incidence rate ratios.
A total of 10 690 ERC patients with sphincterotomy and 10 690 ERC patients without sphincterotomy were included in this analysis. Characteristics of the study population are given in Table 1 . The median age of all patients at ERC was 67 years (range = 15 -94 years); during follow-up, 7791 patients (36%) died and 111 patients (0.52%) were diagnosed with cholangiocarcinoma. Patients with and without sphincterotomy had similar allcause mortality rates throughout followup (data not shown). During year 1 after ERC, the cholangiocarcinoma incidence rate was increased to a similar extent for all ERC patients compared with the rate for the matched population control subjects (>400 vs 12 per 100 000 personyears) ( Table 2 ). During year 2 and years 3 -5 after ERC, the cholangiocarcinoma incidence rate for patients without sphincterotomy was similar to the general population rate (12 and 10, respectively, vs 12 per 100 000 person-years), whereas the rate for sphincterotomy patients remained elevated although it decreased from 79 per 100 000 personyears during year 2 after ERC to 42 per 100 000 person-years during years 3 -5 after ERC ( Table 2 ). More than 5 years after ERC, the cholangiocarcinoma incidence rate for sphincterotomy patients was similar to that for ERC patients without sphincterotomy (27 vs 19 per 100 000 person-years) and slightly higher than the rate for the matched population control subjects ( Table 2 and Figure 1 ). Such similar incidence rates for ERC
CONTEXT AND CAVEATS

Prior knowledge
Sphincterotomy of the ampulla of Vater during endoscopic retrograde cholangiography (ERC) is a common diagnostic and therapeutic procedure that allows reflux of intestinal content into the biliary tree, which results in inflammation that may contribute to malignant transformation of the biliary epithelium and, therefore, increase the risk of cholangiocarcinoma.
Study design
A population-based cohort study using data from Danish health-care registries to examine the incidence of cholangiocarcinoma among ERC patients who did and did not undergo sphincterotomy.
Contribution
The cholangiocarcinoma incidence rates for sphincterotomy patients were 404 per 100 000 person-years during the first year after ERC and decreased progressively at later times after ERC (79, 42, and 27 per 100 000 person-years during years 2, 3 -5, and >5, respectively). The corresponding rates for patients without sphincterotomy were 458, 12, 10, and 19 per 100 000 personyears, respectively.
Implications
Reflux after sphincterotomy does not appear to have a causal role in the development of cholangiocarcinoma.
Limitations
The number of cholangiocarcinomas was small. The association between sphincterotomy and risk of cholangiocarcinoma could be confounded by unknown or unmeasured risk factors for cholangiocarcinoma. 
A positive residual indicates that the adjusted cholangiocarcinoma incidence rate was higher for sphincterotomy patients than for patients without sphincterotomy, a negative residual indicates the opposite. Thus, the fi gure shows how the adjusted incidence rate ratio changed over time after ERC and that it was markedly elevated during years 1 -5 after ERC. Along the x-axes, the timing of cholangiocarcinoma diagnoses is shown with short vertical lines (one for each cholangiocarcinoma diagnosis), and the number of patients remaining in the cohort at 5, 10, 15, 20, and 25 years after ERC is shown with small-font numbers for patients with ( top ) and without ( bottom ) sphincterotomy.
patients with and without sphincterotomy were seen for all three categories of cholangiocarcinoma at more than 5 years after ERC. Confounding was minimal on account of the matching of ERC patients and the small number of cholangiocarcinomas among patients with risk factors ( Table 1 ) , and no interactions were statistically signifi cant. Consequently, the adjusted incidence rate ratios for sphincterotomy patients vs ERC patients without sphincterotomy were similar to the ratio of their crude incidence rates, and they were therefore dependent on the time since ERC, as indicated by the Schoenfeld residuals ( Table 2 and Figure 1 ) . Subdistribution hazards were proportional within all follow-up periods. In the 1000 samplings, the median (5th percentile, 95th percentile) adjusted incidence rate ratios of cholangiocarcinoma during years 1, 2, 3 -5, and more than 5 years after ERC were 0.88 (0.76, 1.01), 6.14 (5.14, 7.87), 3.99 (3.06, 5.26), and 1.67 (1.19, 2.23), respectively.
Our fi nding of an elevated cholangiocarcinoma incidence rate during years 2 -5 after sphincterotomy differs from results of previous smaller studies [reviewed in ( 11 ) ]. The largest study to date ( 12 ) followed 878 Swedish patients starting at 1 year after sphincterotomy; none of the patients developed cholangiocarcinoma during a median follow-up time of 6 years. Given our incidence estimates for sphincterotomy patients, we would have expected two or three cholangiocarcinomas to have been diagnosed in that cohort.
Our fi ndings depend on the validity of registry data. Virtually all surgical procedures and cancer diagnoses are registered correctly, and the small proportion of registered procedures and cancer diagnoses that * ERC patients were matched on sex and age at, calendar year of, and indication for ERC (ie, first three characters of primary diagnosis code given at the time of ERC). ERC = endoscopic retrograde cholangiography. † Cholangitis; biliary duct occlusion (without gallstones), perforation, fistulas, spasms, or cysts; or unspecified biliary disease. ‡ Chronic pancreatitis, pancreatic cysts, pancreatic pseudocysts, or unspecified pancreatic disease. * CI = confidence interval; IRR = incidence rate ratio; ERC = endoscopic retrograde cholangiography. † Cholangiocarcinoma diagnoses per 100 000 person-years. In the matched control subjects from the general population, the cholangiocarcinoma incidence rate over the follow-up period was 12 per 100 000 person-years. ‡ Adjusted for age at ERC, sex, calendar year of ERC, indication for ERC (gallstones, acute pancreatitis, or other), liver cirrhosis, chronic hepatitis B or C infection, and diabetes. No sphincterotomy patients had primary sclerosing cholangitis, so this risk factor was not adjusted for. Also, no patients with inflammatory bowel disease were diagnosed with cholangiocarcinoma during year 1 after ERC, so this risk factor was not adjusted for either. § Adjusted for age at ERC, sex, calendar year of ERC, and indication for ERC (gallstones, acute pancreatitis, or other). No sphincterotomy patients had primary sclerosing cholangitis, so this risk factor was not adjusted for. Also, no patients with liver cirrhosis, chronic hepatitis B or C infection, diabetes, or inflammatory bowel disease were diagnosed with cholangiocarcinoma during year 2 or more than 5 years after ERC, so these risk factors were not adjusted for either.
Appendix
|| Adjusted for age at ERC, sex, calendar year of ERC, indication for ERC (gallstones or acute pancreatitis), and diabetes. No sphincterotomy patients had primary sclerosing cholangitis, so this risk factor was not adjusted for. Also, no patients with "other" indication for ERC, liver cirrhosis, chronic hepatitis B or C infection, diabetes, or inflammatory bowel disease were diagnosed with cholangiocarcinoma during years 3 -5 after ERC, so these risk factors were not adjusted for either.
are incorrect is considered to be acceptable ( 13 -15 ) . Erroneous sphincterotomy or cholangiocarcinoma registration would bias incidence rate ratios toward 1 ( 16 ) and thus cannot explain the elevated cholangiocarcinoma incidence rates we observed for the sphincterotomy patients (vs ERC patients without sphincterotomy) in this study. The very high cholangiocarcinoma incidence rate during year 1 after ERC indicates that many ERC patients had a preexisting but undiagnosed cholangiocarcinoma at the time of their ERC. The elevated but decreasing rate for sphincterotomy patients during years 2 -5 after ERC indicates that a sizable proportion of these existing undiagnosed cholangiocarcinomas was not diagnosed until year 2 after ERC and that a smaller proportion was not diagnosed until years 3 -5 after ERC. It is unclear why undiagnosed cholangiocarcinomas might be more frequent among sphincterotomy patients, but they could not have been caused by refl ux after sphincterotomy. The fact that the cholangiocarcinoma incidence rate for ERC patients without sphincterotomy declined during years 2 -5 after ERC and then increased at later times indicates that diagnostic procedures that were performed during year 1 after ERC led to an earlier diagnosis of cholangiocarcinomas that otherwise would have been diagnosed during years 2 -5 after ERC. The fact that cholangiocarcinoma incidence rates were similar for ERC patients with and without sphincterotomy from 5 years after ERC indicates that refl ux after sphincterotomy does not have a causal role in the development of these cancers.
The strengths of our study were the large number of patients, the complete long-term follow-up, and the populationbased, matched study design. The major limitation was the small number of cholangiocarcinomas. In addition, the association between sphincterotomy and risk of cholangiocarcinoma could be confounded by unknown or unmeasured risk factors for cholangiocarcinoma, but the lack of an association between sphincterotomy and mortality rules out any risk factor that is also associated with mortality. Therefore, smoking and obesity, which may increase the risk of cholangiocarcinoma ( 7 , 8 ) , cannot explain our fi ndings.
In conclusion, sphincterotomy did not appear to be causally related to cholangiocarcinoma in this study.
